Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2801–2850 of 75356
on April 1, 2025, Scott Recknor, the Company’s Head of Asset Management, notified the Company of his decision to retire.
Effective April 11, 2025, Charles Frischer. resigned as a director of Kingsway Financial Services Inc. (“Company”) and member of the Audit Committee.
On April 9, 2025, Michael A. Bender informed the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of his resignation from his position as Executive Vice President, Chief Financial Officer, Treasurer and Secretary of the Company effective as of April 17, 2025.
Dr. Hendrik Strydom, PhD, Chief Technology Officer of the Company, stepped down as a member of the board of directors of the Company
the board of directors of the Company, accepted the resignation of Robert Holcomb.
Scott Recknor, the Company’s Head of Asset Management, notified the Company of his decision to retire.
Ken Myszkowski notified Arrowhead Pharmaceuticals, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of May 13, 2025
On April 9, 2025, Hakan Kardes, Chief Experience Officer of Alignment Healthcare, Inc. (the “Company”), notified the Company of his intention to resign his employment with the Company to pursue other professional opportunities.
Howard Gostfrand and Brian Klatsky resigned from their positions as officers of the Company
Laura Anthony resigned from her positions as a director and officer of the Company
Howard Gostfrand and Brian Klatsky resigned from their positions as officers of the Company
Laura Anthony resigned from her positions as a director and officer of the Company
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
On April 11, 2025, Herbert Alvin (“Hap”) Pollard notified the Company of his resignation as Chief Financial Officer and Treasurer and as a member of the board of directors of Sculptor Diversified Real Estate Income Trust, Inc.
On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer, departed from the Company effective that same date.
Effective June 30, 2025, David D. Kaiser, our Chief Credit Officer, will be retiring and relinquishing all positions he holds with Arrow Financial Corporation (“Arrow”) and its subsidiaries.
Mr. Henry’s previously announced retirement date of April 29, 2025 has been extended to May 2, 2025.
On April 8, 2025, Christopher Wright notified Roper Technologies, Inc. (the “Company”) of his intention to retire from the Company’s Board of Directors, effective as of the Company’s 2025 Annual Meeting of Shareholders to be held on June 10, 2025.
On April 10, 2025, Ms. Luconi and the Company mutually agreed that her final date of employment will be May 2, 2025.
David H. Y. Ho, a member of the Board, notified the Company of his decision to resign from the Board.
John Freund, M.D., a member of the Board of Directors (the “Board”) of Sutro Biopharma, Inc., a Delaware corporation (the “Company”) since 2014, informed the Board of his decision to not stand for re-election to the Board.
On April 12, 2025, Gavin D.K. Hattersley, President and Chief Executive Officer of Molson Coors Beverage Company (the “Company”) and a member of the Company’s Board of Directors (the “Board”), informed the Company and the Board that he intends to retire from the Company and as a member of the Board, in each case, by December 31, 2025.
Pursuant to notice provided on April 8, 2025, Charles Remsberg’s employment as the Chief Sales Officer of the Company will be terminated, effective May 30, 2025.
Effective April 11, 2025, Garth Lees-Rolfe resigned as Chief Financial Officer, principal financial officer and principal accounting officer of Inhibikase Therapeutics, Inc. (the “Company”).
Michael H. Jenkins, the Company’s Chief Executive Officer, has been replaced as Chief Executive Officer of the Company (the “Termination Date”).
On April 13, 2025, Raghib Hussain, President, Products and Technologies of Marvell Technology, Inc. (“Marvell”), notified Marvell of his decision to resign from his position with Marvell effective as of May 2, 2025, to become the Chief Executive Officer of another company.
Bryan Castellani will step down as Executive Vice President and CFO, effective May 5, 2025.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Jensen resigned as Chief Financial Officer
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Chin resigned as Chief Executive Officer
On April 14, 2025, the Company announced that the board of directors of the Company (the “Board”) and Lucinda M. Baier, the Company’s President and Chief Executive Officer and member of the Board, mutually agreed that Ms. Baier’s role serving as the Company’s President and Chief Executive Officer and as a member of the Board would cease, effective as of April 13, 2025.
Mr. Wood’s employment with Adaptimmune Limited will end on August 31, 2025 (the “Revised Termination Date”) by reason of redundancy.
Richard Ziman, Chairman of the Board, will not stand for reelection at the 2025 annual meeting of stockholders (the “Annual Meeting”) as a result of Mr. Ziman’s decision to retire.
On April 10, 2025, Bruce Downey notified the Board of Directors (the “ Board ”) of C4 Therapeutics, Inc. (the “ Company ”) of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders.
Effective April 14, 2025, Bian Fan was removed as Director, Chairperson of the Board of Directors and Chief Executive Officer of DT Cloud Star Acquisition Corporation (the “Company”) by the written consent of the board
On April 14, 2025, Verano Holdings Corp., a British Columbia corporation (the “ Company ”), announced that Brett Summerer resigned as Chief Financial Officer of the Company and from all officer and other positions with its subsidiaries.
On April 12, 2025, Stuart Diamond, a member of the board of directors (the “Board”) of bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), notified the Company of his decision not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On April 9, 2025, Enrique Salem notified Atlassian Corporation (the “ Company ”) of his decision to retire as a director of the Company, effective as of April 14, 2025.
On April 11 th , 2025, James Cardwell resigned his position as CFO of the Corporation.
On April 4, 2025, Gary Kiss resigned from his position as director of BioRegenx, Inc., effective immediately.
On April 7, 2025, Gary Hennerberg resigned from his position as director of BioRegenx, Inc., effective immediately.
On April 14, 2025, Bruce Greenstein notified Viemed Healthcare, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective immediately.
On April 2, 2025, Gerald W. Shields, former Chief Executive Officer and the only non-independent director of the Board of Directors ("Board") of Citizens, Inc. (the “Company”), submitted a written resignation from the Board contingent upon the Board accepting such resignation and selecting an effective date.
all of the members of the Company’s Board of Directors immediately prior to the Effective Time resigned as directors of the Company.
On April 10, 2025, Steven J. Moskowitz, former President and Chief Executive Officer of Crown Castle Inc. (“Company”), effectuated his resignation from the Board of Directors of the Company, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.